Engineering and In Vitro Selection of a Novel AAV3B Variant with High Hepatocyte Tropism and Reduced Seroreactivity is a research paper published in Molecular Therapy — Methods & Clinical Development (2020). On theSindex it has a DataRank of 0. It has been cited 26 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAID NIH HHS
Grant: T32 AI060519
NHLBI NIH HHS
Grant: R01 HL131093
NHLBI NIH HHS
Grant: R01 HL097088
NIAID NIH HHS
Grant: R01 AI051390
National Institutes of Health
Grant: 1R01HL097088-01A2
Next Generation of Recombinant AAV Serotype Vectors for Gene Therapy
National Institutes of Health
Grant: 1R01HL131093-01A1
Enhancing immune regulation in gene therapy for hemophilia
National Institutes of Health
Grant: 7R01AI051390-05
Immunology of Factor IX Gene Transfer to Liver
National Heart, Lung, and Blood Institute
National Institute of Allergy and Infectious Diseases
Fields of Study
Keywords
Sustainable Development Goals